Literature DB >> 19430662

Ocular toxoplasmosis: an update and review of the literature.

Alessandra G Commodaro1, Rubens N Belfort, Luiz Vicente Rizzo, Cristina Muccioli, Claudio Silveira, Miguel N Burnier, Rubens Belfort.   

Abstract

Ocular toxoplasmosis is the most common cause of posterior uveitis worldwide. The infection can be acquired congenitally or postnatally and ocular lesions may present during or years after the acute infection occur. Current treatment controls ocular infection and inflammation, but does not prevent recurrences. We present a review and update on ocular toxoplasmosis and address misconceptions still found in the current medical literature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430662     DOI: 10.1590/s0074-02762009000200030

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  38 in total

1.  Toxoplasmosis: new challenges for an old disease.

Authors:  B Bodaghi; V Touitou; C Fardeau; L Paris; P LeHoang
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

2.  CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.

Authors:  Kazumi Norose; Akitoshi Kikumura; Andrew D Luster; Christopher A Hunter; Tajie H Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

3.  Overlapping Spectrum of Retinochoroidal Scarring in Congenital Zika Virus and Toxoplasmosis Infections.

Authors:  Irena Tsui; Luiza M Neves; Kristina Adachi; Stephanie L Gaw; Jose Paulo Pereira; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira; Andrea A Zin
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-12-01       Impact factor: 1.300

4.  A 26-year-old man with a blind spot in his left eye.

Authors:  Alfred White; Timothy Saunders; Peter Pavan
Journal:  Digit J Ophthalmol       Date:  2013-09-25

5.  Prevalence of toxoplasmosis and related risk factors among humans referred to main laboratories of Urmia city, North West of Iran, 2013.

Authors:  Mohammad Sadaghian; Sasan Amani; Rasool Jafari
Journal:  J Parasit Dis       Date:  2014-08-31

6.  Ocular Toxoplasmosis: Controversies in Primary and Secondary Prevention.

Authors:  Norman A Saffra; Carly J Seidman; Louis M Weiss
Journal:  J Neuroinfect Dis       Date:  2013

Review 7.  DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

Authors:  Carlos García-Estrada; Christopher Fernández Prada; Celia Fernández-Rubio; Francisco Rojo-Vázquez; Rafael Balaña-Fouce
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

8.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

9.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

10.  Changes of inhibitory receptors on NK-92 cells and HLA-G on BeWo cells with Toxoplasma gondii infection.

Authors:  Yang Liu; Ling Zhang; Meilan Gao; Fengmei Zhang; Xiaoyan Xu; Xianbing Liu; Xuemei Hu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.